Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?
about
Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshopVessel caliber--a potential MRI biomarker of tumour response in clinical trials.Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics.Integrated whole body MR/PET: where are we?Pediatric oncology and the future of oncological imaging.Imaging assessment of tumor response: past, present and future.Diffusion-weighted MR imaging of upper abdominal organs at different time points: Apparent diffusion coefficient normalization using a reference organ.How PET/MR Can Add Value For Children With Cancer.T(2)-weighted combined with diffusion-weighted images for evaluating prostatic transition zone tumors at 3 Tesla.Four-dimensional diffusion-weighted MR imaging (4D-DWI): a feasibility study.Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study.Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer.Measurements of metastatic renal cell tumours as determined by diffusion weighted imaging or computed tomography are in close agreement, a pilot study.Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study.Correction of diffusion-weighted magnetic resonance imaging for brachytherapy of locally advanced cervical cancer.Diffusion-weighted magnetic resonance imaging during radiotherapy of locally advanced cervical cancer--treatment response assessment using different segmentation methods.Quantitative magnetic resonance imaging biomarkers in oncological clinical trials: Current techniques and standardization challenges.Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas.Diffusion-Weighted Imaging of Upper Abdominal Organs Acquired with Multiple B-Value Combinations: Value of Normalization Using Spleen as the Reference Organ.2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of t
P2860
Q28079278-C9E69661-DC0E-4988-9EBF-077BE49E06CCQ30651792-6A44C971-63FB-498B-976D-69F3A8ACFF41Q31027315-202EC63D-2A33-430D-9FD9-72F673BA35DAQ33811587-E4922753-14B1-42DE-8767-49C0F3D2EBC0Q34975185-ED9F0581-024D-44FD-AA79-FE74B7AB17FFQ37869417-F1EA8280-A3F7-4C30-B5F9-5A5332666F3AQ37875082-E9B4717F-D20E-4B86-8C1E-2B8B7D028AFCQ38822069-5FEB1DD6-E45A-4FA6-96A6-3C2FF52CFC49Q39427334-D814DE64-3DFE-4F8D-8BCD-40BE2CCA146BQ39439451-ABFE925F-B370-4741-91FE-3506F5A36734Q40438007-831544FC-6203-4CA5-8934-E752DDB432D5Q41534428-DDAC6977-DC3A-4869-9635-71BF7ABCB3F0Q41881716-4B66118E-9B2B-4FDB-AEAA-390B181DE37FQ42291319-7861700D-DECE-4304-BAA5-F75BCE224AAFQ45929472-A8766A5F-DBE9-49BF-AF31-68DDD55E780BQ48847870-84D0C4DE-DDCB-4C7B-9474-43BC67CFE827Q51831342-DFBD3C72-C753-4DAF-B496-E3858199C5EDQ52904949-16A4CF8E-A172-423F-BDF0-E6AA947EB1DCQ55261716-B6C5DC1C-BF5E-4A5D-A8BF-134CCE26091DQ55270603-C0B003DA-075E-4FC9-9308-2DADDA29C4E8Q55454935-0A225013-A5F6-429F-9092-4C581CE9B11E
P2860
Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@ast
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@en
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@nl
type
label
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@ast
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@en
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@nl
prefLabel
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@ast
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@en
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@nl
P2860
P1433
P1476
Diffusion-weighted magnetic re ...... assessment: why, when and how?
@en
P2093
P2860
P304
P356
10.1102/1470-7330.2010.9032
P478
10 Spec no A
P50
P577
2010-10-04T00:00:00Z